11-63629327-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015459.5(ATL3):c.1618G>T(p.Ala540Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015459.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATL3 | NM_015459.5 | c.1618G>T | p.Ala540Ser | missense_variant | Exon 13 of 13 | ENST00000398868.8 | NP_056274.3 | |
ATL3 | NM_001290048.2 | c.1564G>T | p.Ala522Ser | missense_variant | Exon 13 of 13 | NP_001276977.1 | ||
ATL3 | XM_047426725.1 | c.1774G>T | p.Ala592Ser | missense_variant | Exon 14 of 14 | XP_047282681.1 | ||
ATL3 | XM_006718493.2 | c.1561G>T | p.Ala521Ser | missense_variant | Exon 12 of 12 | XP_006718556.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152122Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249550Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135390
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461594Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727122
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152122Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74302
ClinVar
Submissions by phenotype
Neuropathy, hereditary sensory, type 1F Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 540 of the ATL3 protein (p.Ala540Ser). This variant is present in population databases (rs749790717, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ATL3-related conditions. ClinVar contains an entry for this variant (Variation ID: 1776545). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The p.A540S variant (also known as c.1618G>T), located in coding exon 13 of the ATL3 gene, results from a G to T substitution at nucleotide position 1618. The alanine at codon 540 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at